NanoDimension

Total investments

44

Average round size

30M

Portfolio companies

19

Rounds per year

2.10

Lead investments

10

Follow on index

0.57

Exits

8

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryHealth CareMedicalLife SciencePharmaceuticalTherapeuticsElectronicsBiopharmaNanotechnology

Summary

NanoDimension is the famous VC, which was founded in 2002. The fund was located in North America if to be more exact in Cayman Islands. The main department of described VC is located in the Grand Cayman.

We can highlight the next thriving fund investment areas, such as Biotechnology, Electronics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline ARMO BioSciences, View, Icosavax

The top amount of exits for fund were in 2018. Comparing to the other companies, this NanoDimension performs on 15 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 17 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually.

The current fund was established by Aymeric Sallin. The overall number of key employees were 5.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NanoDimension, startups are often financed by Flagship Pioneering, Polaris Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Paladin Capital Group, Foresite Capital. In the next rounds fund is usually obtained by Flagship Pioneering, RUSNANO, Paladin Capital Group.

Show more

Investments analytics

Analytics

Total investments
44
Lead investments
10
Exits
8
Rounds per year
2.10
Follow on index
0.57
Investments by industry
  • Biotechnology (31)
  • Health Care (24)
  • Life Science (14)
  • Therapeutics (9)
  • Medical (8)
  • Show 30 more
Investments by region
  • United States (42)
  • Switzerland (2)
Peak activity year
2016
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
304M
Group Appearance index
0.95
Avg. company exit year
10
Avg. multiplicator
0.99
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ARMO BioSciences 28 May 2014 Biotechnology, Health Care, Medical Device Early Stage Venture 30M United States, California, Redwood City
Inscripta 04 Apr 2019 Biotechnology, Health Care, Life Science Late Stage Venture 20M United States, Boulder, Colorado

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.